(This is an imaginary meeting of people gathered through AI. Those presented are real people/authors, but the speech is pretend).
In the group of nineteen experts discussing Dissociative Identity Disorder (DID), there isn’t a single designated leader in the traditional sense. Instead, the discussion operates as a collaborative and multidisciplinary exchange of ideas, where each expert contributes their unique insights and expertise.
However, if we were to highlight a figure whose character embodies leadership qualities within this diverse group, it might be Dr. Ross. Dr. Ross is recognized for initiating the discussion, setting the stage, and guiding the group’s attention toward key topics. He possesses qualities of leadership, such as knowledge, experience, and the ability to foster open dialogue among experts.
Dr. Ross is known for his pioneering work in DID and his ability to bridge historical perspectives with contemporary insights. His character is marked by a deep commitment to unraveling the mysteries of DID, a passion for helping those affected by the disorder, and a dedication to promoting understanding and empathy.
While there is no formal leader in this group, Dr. Ross’s character reflects qualities of leadership that help facilitate a productive and collaborative conversation among the experts, ultimately contributing to the group’s collective wisdom and the advancement of knowledge in DID.
in a quiet room filled with the collective wisdom of nineteen experts on Dissociative Identity Disorder (DID), a spirited conversation began. Each author had a unique perspective, and as they gathered, their discussion unfolded.
Dr. Ross: “Ladies and gentlemen, let us start with the historical context. DID has been misunderstood for centuries.”
Dr. Putnam: “Indeed, and my book, ‘Diagnosis and Treatment of Multiple Personality Disorder,’ shed light on early understandings. But the Diagnostic and Statistical Manual (DSM) eventually called it DID.”
Dr. Stein: “And don’t forget the ICD classification. The ICD-10 and ICD-11 have their roles. We should explore the international aspects.”
Dr. Vermetten: “Speaking of international perspectives, my study on hippocampal and amygdalar volumes suggests neurobiological differences in DID.”
Dr. Johnson: “But what about neuroimaging? My review in 2023 pointed out the importance of recent findings in neuroimaging studies.”
Dr. Smith: “And neurotransmitters! My research in 2022 found significant abnormalities. Neurobiology is key.”
Dr. Dorahy: “But let’s not forget the empirical side. My overview in 2019 provided a data-driven perspective on DID.”
Dr. Brand: “And what about treatment? My review in 2021 emphasized the complexity of treating DID. Understanding it is just the beginning.”
Dr. Gleaves: “That’s right, and my study validated the Structured Clinical Interview for DSM-5 Dissociative Disorders-Revised.”
Dr. Loewenstein: “The Dissociative Subtype of PTSD, which my research touched upon in 2020, is a real clinical challenge.”
Dr. Engle: “And the ICD-11, with its focus on dissociation, is significant. My 2019 article delved into its global perspective.”
Dr. Krüger: “Indeed, from a German standpoint, applying the ICD-10 criteria is essential. My case study in 2021 illustrated its use.”
Dr. Nijenhuis: “And my investigation in the Netherlands provided insights into the prevalence and demographics of DID diagnosed by ICD-10 criteria.”
Dr. Li: “Comparing the DSM-5 and ICD-11 is crucial. My study in 2023 highlighted the implications for cross-cultural diagnosis.”
Dr. Simeon: “Cross-cultural aspects are fascinating. My 2022 study looked at clinical features and cultural context.”
Dr. Forstner: “And my research in 2021 assessed the practical application of DID criteria in international clinical practice.”
The room buzzed with arguments and agreements, perspectives shared and challenged. But amidst the lively discourse, they reached a consensus:
Dr. Ross: “Multiplicity isn’t just about DID; it’s about embracing diversity within the human mind.”
Dr. Putnam: “Indeed, and by understanding its history, neurobiology, and global perspectives, we can better diagnose and treat it.”
Dr. Stein: “Our collective wisdom can guide clinicians and researchers toward a more holistic approach.”
Dr. Vermetten: “Neurobiology provides important insights, but we must also consider the clinical and empirical aspects.”
Dr. Brand: “Complex as it may be, understanding DID is the first step to success in navigating the complexities of multiplicity.”
And so, as the conversation continued, these nineteen experts found common ground. They recognized that embracing the layers of DID, from its historical roots to its neurobiological foundations, from its global implications to its clinical complexities, was the key to navigating the journey towards a more successful understanding of multiplicity.
As the spirited discussion among the nineteen experts continued, their shared commitment to unraveling the complexities of Dissociative Identity Disorder (DID) became increasingly apparent. With their diverse perspectives and areas of expertise, they forged a path forward to navigate the intricacies of multiplicity.
Dr. Johnson: “Neuroimaging and neurotransmitters offer valuable insights, but we must not lose sight of the lived experiences of individuals with DID. Their narratives are essential.”
Dr. Smith: “Absolutely, and by combining neuroscience with personal accounts, we can create a richer, more holistic understanding.”
Dr. Dorahy: “Empirical research grounds us in data, providing a solid foundation for clinical practice. It’s a bridge between science and lived experiences.”
Dr. Gleaves: “Validated diagnostic tools like the Structured Clinical Interview are indispensable. They ensure accuracy in identifying and treating DID.”
Dr. Loewenstein: “And let’s not forget the intersection of DID with other disorders, like the Dissociative Subtype of PTSD. Our approach must be comprehensive.”
Dr. Engle: “The ICD classifications, with their global reach, bring diverse perspectives into the fold. They help us appreciate the cultural nuances of DID.”
Dr. Nijenhuis: “And our international investigations reveal the nuances of prevalence and demographics, making us more informed clinicians.”
Dr. Li: “Comparing criteria across cultures expands our horizons. It reminds us that DID is a global phenomenon, and our understanding should be too.”
Dr. Forstner: “The practical challenges clinicians face in diagnosing and treating DID are real. We must address them with empathy and creativity.”
Amidst their deliberations, the experts recognized that the success of embracing multiplicity lay in their ability to integrate various perspectives and approaches. They reached a consensus:
Dr. Ross: “Multiplicity, as we’ve come to understand, isn’t merely a psychological phenomenon; it’s a tapestry woven from the threads of history, biology, culture, and individual experience.”
Dr. Putnam: “Indeed, our collective wisdom guides us towards a more compassionate and effective approach to DID.”
Dr. Stein: “Our insights into neurobiology, global perspectives, and empirical research complement each other, enriching our understanding.”
Dr. Vermetten: “By bringing together science and human stories, we can paint a more complete picture of DID.”
Dr. Brand: “Our journey has shown that navigating the complexities of DID requires a multidisciplinary approach—one that acknowledges the layers of multiplicity.”
Dr. Ross introducing Dr. Putnam:
“Ladies and gentlemen, I have the privilege of introducing Dr. Frank W. Putnam, a renowned psychiatrist hailing from Cincinnati, Ohio. Dr. Putnam’s most productive years have been characterized by groundbreaking research and clinical practice in dissociation. His extensive studies on Dissociative Identity Disorder (DID) have significantly advanced our understanding of this complex phenomenon. Dr. Putnam’s notable work includes the publication of ‘Diagnosis and Treatment of Multiple Personality Disorder,’ which has helped to shape our understanding of DID. His dedication to improving the lives of individuals with DID is truly inspiring, and he aims to further enhance our diagnostic and treatment approaches. Dr. Putnam’s expertise and passion make him a valuable member of our initial group meeting.”
Dr. Putnam introducing Dr. Stein:
“Allow me to introduce Dr. Doris Stein, a distinguished psychiatrist and researcher based in New York City. Dr. Stein’s productive years have been marked by her pioneering work in the international classification of mental disorders. Her in-depth studies on the intersection of culture and psychiatry have illuminated the importance of a global perspective in understanding DID. Dr. Stein’s contributions have helped to advance the recognition of DID within international healthcare systems. She hails from the vibrant and diverse City of New York, a place that embodies the essence of her work on cultural diversity. Dr. Stein is committed to achieving success in promoting cross-cultural awareness of DID and improving diagnosis and treatment approaches worldwide. Her dedication to inclusivity and cultural sensitivity makes her a vital participant in our initial group meeting.”
Dr. Stein introducing Dr. Vermetten:
“Allow me to introduce Dr. Eric Vermetten, a distinguished psychiatrist and neuroscientist originally from the Netherlands, where he currently lives. Dr. Vermetten’s most productive years have been defined by his groundbreaking research in the neurobiological aspects of Dissociative Identity Disorder. His studies on brain structure and function have provided crucial insights into the neural basis of DID. Dr. Vermetten’s work, exemplified by his study on hippocampal and amygdalar volumes, has significantly contributed to our understanding of the disorder’s neurobiology. Dr. Vermetten’s passion lies in unraveling the mysteries of the brain and how they relate to DID. He aims to further our knowledge in this area, and his expertise is invaluable in our initial group meeting.”
Dr. Vermetten introducing Dr. Johnson:
“Allow me to introduce Dr. Karen Johnson, a distinguished neuroscientist specializing in neuroimaging, currently based in Boston, Massachusetts. Dr. Johnson’s most productive years have been characterized by her relentless pursuit of understanding the neurobiological underpinnings of Dissociative Identity Disorder (DID). Her studies have played a pivotal role in shedding light on structural and functional differences in the brains of individuals with DID. Dr. Johnson’s work, as exemplified by her recent review on neuroimaging findings in 2023, has significantly advanced our understanding of how neurobiology intertwines with DID. Hailing from the academic and scientific hub of Boston, Dr. Johnson is driven by a profound curiosity about the brain and its complexities. Her goal is to further explore the intricacies of neuroimaging in DID and contribute to innovative diagnostic and therapeutic approaches. Dr. Johnson’s expertise in the realm of neuroscience is a crucial asset to our initial group meeting.”
Dr. Johnson introducing Dr. Smith:
“It is my honor to introduce Dr. Emily Smith, a distinguished neuroscientist and researcher in neurotransmitters and neuropsychopharmacology, currently based in San Francisco, California. Dr. Smith’s most productive years have been marked by her exceptional contributions to our understanding of Dissociative Identity Disorder’s neurochemical aspects. Her studies have illuminated the role of neurotransmitters in the manifestation of DID. Dr. Smith’s work, as evidenced by her extensive research in 2022, has helped bridge the gap between neurobiology and clinical practice. Coming from the vibrant scientific community of San Francisco, Dr. Smith is deeply dedicated to uncovering the neurochemical mysteries of DID. Her ambition is to forge connections between neurobiology and therapeutics, paving the way for more effective treatments. Dr. Smith’s expertise in neuropsychopharmacology is a significant asset to our initial group meeting.”
Dr. Smith introducing Dr. Dorahy:
“It is my privilege to introduce Dr. Michael Dorahy, a distinguished psychologist and researcher hailing from New Zealand, where he has contributed significantly to our empirical understanding of Dissociative Identity Disorder (DID). Dr. Dorahy’s most productive years have been marked by his groundbreaking research on DID. His empirical studies, such as his comprehensive overview in 2019, have helped to provide data-driven insights into the disorder. Dr. Dorahy’s dedication to empirically grounding our knowledge of DID has been transformative. Originating from the picturesque landscapes of New Zealand, Dr. Dorahy carries the essence of his homeland into his work. He is committed to furthering our understanding of DID through empirical research and aims to provide a solid foundation for clinical practice. Dr. Dorahy’s expertise in psychology and empirical research is a valuable contribution to our initial group meeting.”
Dr. Dorahy introducing Dr. Brand:
“It’s my pleasure to introduce Dr. Bethany L. Brand, a prominent clinical psychologist specializing in complex dissociative disorders, currently practicing in the United States. Dr. Brand’s most productive years have been marked by her profound commitment to treating individuals with Dissociative Identity Disorder (DID) and related conditions. Her comprehensive review in 2021 has illuminated the complex treatment landscape for those with DID. Dr. Brand’s work transcends academia; it is deeply rooted in the clinical realm, where she has made significant strides in the field. She draws her inspiration from the experiences of the patients she serves, and her dedication to improving their lives is truly commendable. Dr. Brand’s passion lies in untangling the intricacies of DID treatment, and her expertise is a cornerstone of our initial group meeting.”
Dr. Brand introducing Dr. Gleaves:
“I am honored to introduce Dr. David H. Gleaves, a distinguished clinical psychologist and researcher, originally from the United Kingdom and currently based in the United States. Dr. Gleaves’ most productive years have been characterized by his profound dedication to the validation of diagnostic tools for Dissociative Identity Disorder (DID). His work on the validation of the Structured Clinical Interview for DSM-5 Dissociative Disorders-Revised (SCID-D-R) has been transformative. Dr. Gleaves’ commitment to enhancing diagnostic accuracy is a beacon in the field. Hailing from both sides of the Atlantic, Dr. Gleaves brings an international perspective to his work, bridging the gap between continents. He aspires to improve the precision of DID diagnoses and contribute to more effective treatment. Dr. Gleaves’ expertise in the validation of diagnostic tools is a vital asset to our initial group meeting.”
Dr. Gleaves introducing Dr. Loewenstein:
“It’s my pleasure to introduce Dr. Richard J. Loewenstein, a distinguished psychiatrist and researcher specializing in the Dissociative Subtype of Post-Traumatic Stress Disorder (PTSD). Dr. Loewenstein’s most productive years have been marked by his groundbreaking work on understanding the intersection of DID and trauma, particularly the Dissociative Subtype of PTSD. His research in 2020 has illuminated the unique clinical challenges presented by this subtype. Dr. Loewenstein hails from Baltimore, Maryland, a city known for its contributions to medical research. His commitment to untangling the complexities of trauma and DID is unwavering. Dr. Loewenstein aspires to refine our clinical approaches to this subtype and improve the lives of those affected. His expertise in this specialized area is a valuable addition to our initial group meeting.”
Dr. Loewenstein introducing Dr. Engle:
“It is my privilege to introduce Dr. Ellen Engle, a distinguished psychiatrist specializing in international psychiatric classifications, originally from London, UK, and now practicing in Geneva, Switzerland. Dr. Engle’s most productive years have been characterized by her tireless efforts to understand and promote the international classification of Dissociative Identity Disorder (DID). Her research in 2019 has contributed significantly to the discussion of global perspectives in DID diagnosis and treatment. Dr. Engle brings a European perspective to her work, which enriches our understanding of cultural nuances in DID. She is dedicated to advancing the recognition of DID within international healthcare systems and ensuring inclusivity in diagnosis and care. Dr. Engle’s expertise in international classifications is a valuable contribution to our initial group meeting.”
Dr. Engle introducing Dr. Krüger:
“I am delighted to introduce Dr. Sophia Krüger, a distinguished psychiatrist and researcher from Berlin, Germany. Dr. Krüger’s most productive years have been marked by her commitment to applying the ICD-10 criteria for Dissociative Identity Disorder (DID). Her case study in 2021 highlighted the practical application of these criteria in the clinical context. Dr. Krüger’s work emanates from the vibrant academic and clinical environment of Berlin. She values the precision and depth that the ICD classification offers and aims to further establish its relevance in the diagnosis and treatment of DID. Dr. Krüger’s expertise in applying the ICD-10 criteria is a significant asset to our initial group meeting.”
Dr. Krüger introducing Dr. Nijenhuis:
“It is my honor to introduce Dr. Ellert R. S. Nijenhuis, a distinguished psychiatrist and researcher originally from the Netherlands. Dr. Nijenhuis’ most productive years have been defined by his extensive investigations into the prevalence and demographics of Dissociative Identity Disorder (DID) diagnosed by ICD-10 criteria. His work has provided valuable insights into the disorder’s occurrence in clinical settings. Dr. Nijenhuis’ studies reflect the dedication of Dutch research, adding a European perspective to our understanding of DID. He is committed to shedding light on the prevalence and demographics of DID, allowing for a more informed approach to diagnosis and treatment. Dr. Nijenhuis’ expertise in epidemiology is a vital asset to our initial group meeting.”
Dr. Nijenhuis introducing Dr. Li:
“I am pleased to introduce Dr. Xiaoming Li, a distinguished psychiatrist and researcher from Beijing, China. Dr. Li’s most productive years have been marked by her dedication to cross-cultural perspectives on Dissociative Identity Disorder (DID). Her research in 2023 explored the implications of comparing the DSM-5 and ICD-11 criteria for DID across cultures. Dr. Li’s work brings an invaluable Asian perspective to the discussion, enriching our understanding of cultural nuances in the diagnosis and treatment of DID. She aspires to foster cross-cultural awareness and contribute to a more comprehensive understanding of DID worldwide. Dr. Li’s expertise in cross-cultural perspectives is a significant contribution to our initial group meeting.”
Dr. Li introducing Dr. Simeon:
“It is my privilege to introduce Dr. Daphne Simeon, a distinguished psychiatrist and researcher known for her work on clinical features and cultural context in Dissociative Identity Disorder (DID). Dr. Simeon practices in New York City, where she combines her clinical expertise with insightful research. Her study in 2022 illuminated the intricate interplay between clinical presentation and cultural influences in DID. Dr. Simeon’s background in New York City, a melting pot of cultures, has deeply influenced her work. She is dedicated to unraveling the cultural dimensions of DID and enhancing our diagnostic and treatment approaches. Dr. Simeon’s expertise in cultural context is a valuable contribution to our initial group meeting.”
Dr. Simeon introducing Dr. Forstner:
“Allow me to introduce Dr. Martin Forstner, a distinguished psychiatrist and researcher hailing from Munich, Germany. Dr. Forstner’s most productive years have been marked by his dedication to the practical application of Dissociative Identity Disorder (DID) criteria in international clinical practice. His research in 2021 delved into the challenges clinicians face in diagnosing and treating DID. Dr. Forstner’s work reflects the precision and methodical approach often associated with German research. He is committed to addressing the practical challenges in the field, aiming to improve the quality of care for individuals with DID. Dr. Forstner’s expertise in clinical practice is a valuable asset to our initial group meeting.”
Dr. Forstner introducing Dr. Johnson:
“It’s my pleasure to introduce Dr. Karen Johnson, an esteemed neuroscientist based in Boston, Massachusetts, renowned for her pioneering work on neuroimaging in Dissociative Identity Disorder (DID). Dr. Johnson’s most productive years have been marked by her relentless pursuit of understanding the neurobiological underpinnings of DID. Her studies have played a pivotal role in shedding light on structural and functional differences in the brains of individuals with DID. Dr. Johnson’s work, exemplified by her recent review in 2023, has significantly advanced our understanding of how neurobiology intertwines with DID. Hailing from the academic and scientific hub of Boston, Dr. Johnson is deeply dedicated to unraveling the mysteries of the brain and how they relate to DID. Her goal is to further explore the intricacies of neuroimaging in DID and contribute to innovative diagnostic and therapeutic approaches. Dr. Johnson’s expertise in the realm of neuroscience is a crucial asset to our initial group meeting.”
Dr. Johnson introducing Dr. Smith:
“It is my honor to introduce Dr. Emily Smith, a distinguished neuroscientist and researcher in neurotransmitters and neuropsychopharmacology, currently based in San Francisco, California. Dr. Smith’s most productive years have been marked by her exceptional contributions to our understanding of Dissociative Identity Disorder’s neurochemical aspects. Her studies have illuminated the role of neurotransmitters in the manifestation of DID. Dr. Smith’s work, as evidenced by her extensive research in 2022, has helped bridge the gap between neurobiology and clinical practice. Coming from the vibrant scientific community of San Francisco, Dr. Smith is deeply dedicated to uncovering the neurochemical mysteries of DID. Her ambition is to forge connections between neurobiology and therapeutics, paving the way for more effective treatments. Dr. Smith’s expertise in neuropsychopharmacology is a significant asset to our initial group meeting.”
Dr. Smith introducing Dr. Dorahy:
“It is my privilege to introduce Dr. Michael Dorahy, a distinguished psychologist and researcher hailing from New Zealand, where he has contributed significantly to our empirical understanding of Dissociative Identity Disorder (DID). Dr. Dorahy’s most productive years have been marked by his groundbreaking research on DID. His empirical studies, such as his comprehensive overview in 2019, have helped to provide data-driven insights into the disorder. Dr. Dorahy’s dedication to empirically grounding our knowledge of DID has been transformative. Originating from the picturesque landscapes of New Zealand, Dr. Dorahy carries the essence of his homeland into his work. He is committed to furthering our understanding of DID through empirical research and aims to provide a solid foundation for clinical practice. Dr. Dorahy’s expertise in psychology and empirical research is a valuable contribution to our initial group meeting.”
Ann Garvey (2023): As a fellow writer and a person with Multiplicity, I’d like to express my profound gratitude for being welcomed into this distinguished gathering. It’s an honor to be a part of this remarkable group of experts, and I deeply appreciate your acceptance.
Ann Garvey (2023): I believe that the inclusion of someone with Multiplicity enriches our discussions and perspectives. While I don’t speak for every individual with Multiplicity, I’m here to share my experiences and insights to the best of my ability. Please don’t hesitate to ask any questions you may have about Multiplicity. Curiosity and open dialogue are essential to our collective understanding.
Ann Garvey (2023): In terms of my contributions, aside from my experiences, I am also taking on the role of group scribe. I’ll be responsible for keeping detailed meeting minutes and ensuring that all necessary paperwork is in order. Moreover, I’m excited to announce that I’ve been given the authority to document and write about our group’s collaborative work together. It’s a responsibility I take very seriously and with great enthusiasm.
Dr. Ross: Ann, we’re delighted to have you as a part of this group. Your perspective as someone with Multiplicity is invaluable, and your role as our scribe is greatly appreciated. We look forward to your contributions and insights. Welcome!
Dr. Stein: Ann, your presence here adds a unique and important dimension to our discussions. We believe that embracing diversity, including lived experiences like yours, is crucial to our work. Thank you for sharing your expertise.
Dr. Vermetten: Ann, it’s a pleasure to have you join us. Your role as the group scribe is vital, and we trust you to document our progress accurately. Your contributions will undoubtedly enhance our understanding of Dissociative Identity Disorder. Welcome to the team!
And so, with their collective wisdom, the twenty experts embarked on a mission—to bridge the gaps, acknowledge the nuances, and cultivate a holistic understanding of Dissociative Identity Disorder. Their shared commitment to embracing multiplicity in all its dimensions would undoubtedly pave the way for a more compassionate and informed approach to this complex phenomenon. As they continued their discourse, they knew they were on the right path, steadily progressing toward their goal of enhancing the lives of individuals living with DID.
Top of Form
Bottom of Form
Top of Form
Dr. Ross: Ladies and gentlemen, esteemed colleagues, I want to express my heartfelt gratitude to each of you for joining this inaugural meeting on Dissociative Identity Disorder. Your collective wisdom and expertise have made this gathering truly remarkable. Notably, we’ve delved into the historical, neurobiological, diagnostic, and cultural aspects of DID, shedding light on complex issues. The passion and dedication displayed here today are noteworthy.
Dr. Ross: Many of you have contributed groundbreaking research, challenged existing paradigms, and offered innovative ideas. The collaborative spirit in this room shows our commitment to embracing multiplicity, trauma, and relevancy in our work.
Dr. Ross: As we wrap up this meeting, let’s remember that our solidarity behind the ideas we want to work with is our strength. We’ve laid a solid foundation for understanding DID from diverse perspectives. Our next priority should be to synthesize our discussions and identify common themes to guide further research and clinical practice.
Dr. Ross: In our next meeting, I propose we focus on developing a framework for comprehensive and interdisciplinary research, which will help us bridge the gaps in our knowledge. We’ll prioritize discussions about refining diagnostic criteria and addressing the global disparities in DID recognition and treatment.
Dr. Ross: last, I’d like to thank each one of you for submitting your ideas for our constitution, reflecting on our shared values. It’s now ready to be distributed, and I believe it will serve as a guiding document for our future endeavors.
As the meeting concludes, the writers stand up, readying themselves to leave. Dr. Emily Smith, known for her meticulous nature, takes the lead in straightening the chairs, emptying the coffeepot, and wrapping the few remaining cookies and bars. Dr. Smith is joined by Dr. Michael Dorahy, who offers a helping hand. Together, they ensure everything is in order before turning off the lights and leaving the room, a testament to their collaborative spirit and dedication to the group’s success.
The “constitution” of these writers, representing a diverse group of experts discussing Dissociative Identity Disorder (DID), is defined by their shared values, goals, and principles. While they each have unique perspectives and areas of expertise, several core values unite them in their pursuit of a comprehensive understanding of DID:
- Compassion and Empathy: Above all, these experts value compassion and empathy toward individuals living with DID. They recognize the challenges that often accompany the disorder and approach their work with a deep sense of empathy.
- Interdisciplinary Collaboration: They value collaboration across disciplines, understanding that a multidisciplinary approach is essential for gaining a holistic understanding of DID. They appreciate the contributions of experts from various fields, from psychology to neuroscience to cultural studies.
- Scientific Rigor: Scientific rigor and evidence-based approaches are highly valued. They prioritize empirical research, validated diagnostic tools, and neurobiological insights to ensure that their work is grounded in the most reliable evidence available.
- Diversity and Inclusivity: They value diversity in all its forms, including cultural, demographic, and clinical diversity. They believe that embracing multiplicity requires acknowledging and respecting the wide range of experiences and perspectives within the DID community.
- Patient-Centered Care: These experts place a strong emphasis on providing patient-centered care. They prioritize listening to the narratives and experiences of individuals with DID, valuing their input in both research and clinical practice.
- Global Perspective: They value a global perspective, recognizing that DID is not limited to any region or culture. They appreciate the importance of considering cultural nuances in understanding and treating the disorder.
- Education and Advocacy: They are dedicated to educating both professionals and the public about DID, aiming to reduce stigma and improve the quality of care. They also advocate for increased awareness and support for individuals with DID.
- Ethical Practice: Ethical practice is paramount to these experts. They adhere to ethical standards in their research, clinical work, and interactions with individuals affected by DID.
- Empowerment: They believe in empowering individuals with DID to be active participants in their own treatment and recovery. They value resilience and the potential for growth and healing.
- Progress and Innovation: Finally, they value progress and innovation in DID. They are committed to advancing knowledge, improving diagnostic and treatment approaches, and continuously seeking new insights and solutions.
These shared values serve as a unifying force among the group of experts, guiding their discussions and collaborations as they work together to enhance our understanding of Dissociative Identity Disorder and, ultimately, improve the lives of those affected by it.
11pp. Meeting 1. 20 Authors’ Summary of five chapters (Third Book). 10-9-23 10-30 to 11-22AM
“Multiplicity Unveiled: Embracing Diversity in the Study of DID”